Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001877850 | SCV002145910 | pathogenic | X-linked Emery-Dreifuss muscular dystrophy | 2024-03-11 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 3 of the EMD gene. It does not directly change the encoded amino acid sequence of the EMD protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with Emery-Dreifuss muscular dystrophy (PMID: 7894480, 34906502; Invitae). This variant is also known as A to G at -3 from 324. ClinVar contains an entry for this variant (Variation ID: 1374482). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in retention of intron 3 and introduces a premature termination codon (PMID: 7894480). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV001877850 | SCV000032158 | pathogenic | X-linked Emery-Dreifuss muscular dystrophy | 1994-12-01 | no assertion criteria provided | literature only |